Obesity is a chronic disease that can be treated with comprehensive and lifelong care, so people should not expect a one-time treatment through medication, the Taiwan Medical Association for the Study of Obesity said yesterday, as it released the 2025 Clinical Practice Guidelines on Adult Obesity in Taiwan.
The clinical practice guidelines were announced at the 25th annual congress of the association in conjunction with the 9th Japan-Korea-Taiwan Symposium on Obesity at National Taiwan University Hospital’s International Convention Center in Taipei.
The association said the new guidelines align with the WHO’s latest fact sheet on obesity and its global guidelines on the use of glucagon-like peptide-1 (GLP-1) therapies in treating obesity, issued earlier this month.
Photo: CNA
Association president Lin Wen-yuan (林文元) said the WHO’s new guidelines recognize that obesity is “a chronic disease that can be treated with comprehensive and lifelong care,” and that GLP-1 therapies might be used by adults for the long-term treatment of obesity, adding that it also stressed that medication alone could not reverse the serious health challenge.
The WHO classifies obesity as “a chronic, relapsing disease arising from complex interactions between genetics, neurobiology, eating behaviors, access to healthy diet, market forces and the broader environment.”
GLP-1 therapies could support people in overcoming obesity, as “a part of a comprehensive approach that includes healthy diets, regular physical activity and support from health professionals,” the WHO says.
Lin said the 2025 Clinical Practice Guidelines on Adult Obesity in Taiwan redefined obesity — not only looking at a person’s body mass index (BMI), but also their waist circumference, body composition and metabolic risks — allowing the diagnosis to be more refined.
The guidelines also added more diversity to the recommended treatment of obesity, including lifestyle adjustments, nutrition intake and regular physical activity plans, mental support, medications (including GLP-1 therapies), endoscopic bariatric therapy, and bariatric surgery, he said.
Moreover, the guidelines provide more customized care recommendations for different groups of people with obesity, including elderly people, pregnant women or women going through menopause, he said.
They also emphasize patient-centric treatment with empathetic communication, while refusing stigmatization, he said.
The WHO defines obesity as having a BMI of 30 or higher in adults, and Taiwan’s guidelines define it as a BMI of 27 or higher.
Association secretary-general Kao Hsiang-han (高湘涵) said according to the new guidelines, people with a BMI of 27 or higher, along with at least one comorbidity, are eligible for GLP-1 therapy, while people with a BMI of 24 to 27 are overweight, meaning that they are advised to first receive lifestyle intervention for several months before considering the use of GLP-1 therapies.
However, Lin said the association has also observed abusive use of GLP-1 therapies, such as being used by people who are not obese or excessive use, which could cause health risks including substantial muscle loss.
People should only receive GLP-1 therapies prescribed and monitored by health professionals, he added.
Additional reporting by CNA
DAREDEVIL: Honnold said it had always been a dream of his to climb Taipei 101, while a Netflix producer said the skyscraper was ‘a real icon of this country’ US climber Alex Honnold yesterday took on Taiwan’s tallest building, becoming the first person to scale Taipei 101 without a rope, harness or safety net. Hundreds of spectators gathered at the base of the 101-story skyscraper to watch Honnold, 40, embark on his daredevil feat, which was also broadcast live on Netflix. Dressed in a red T-shirt and yellow custom-made climbing shoes, Honnold swiftly moved up the southeast face of the glass and steel building. At one point, he stepped onto a platform midway up to wave down at fans and onlookers who were taking photos. People watching from inside
A Vietnamese migrant worker yesterday won NT$12 million (US$379,627) on a Lunar New Year scratch card in Kaohsiung as part of Taiwan Lottery Co’s (台灣彩券) “NT$12 Million Grand Fortune” (1200萬大吉利) game. The man was the first top-prize winner of the new game launched on Jan. 6 to mark the Lunar New Year. Three Vietnamese migrant workers visited a Taiwan Lottery shop on Xinyue Street in Kaohsiung’s Gangshan District (崗山), a store representative said. The player bought multiple tickets and, after winning nothing, held the final lottery ticket in one hand and rubbed the store’s statue of the Maitreya Buddha’s belly with the other,
‘NATO-PLUS’: ‘Our strategic partners in the Indo-Pacific are facing increasing aggression by the Chinese Communist Party,’ US Representative Rob Wittman said The US House of Representatives on Monday released its version of the Consolidated Appropriations Act, which includes US$1.15 billion to support security cooperation with Taiwan. The omnibus act, covering US$1.2 trillion of spending, allocates US$1 billion for the Taiwan Security Cooperation Initiative, as well as US$150 million for the replacement of defense articles and reimbursement of defense services provided to Taiwan. The fund allocations were based on the US National Defense Authorization Act for fiscal 2026 that was passed by the US Congress last month and authorized up to US$1 billion to the US Defense Security Cooperation Agency in support of the
HIGH-TECH DEAL: Chipmakers that expand in the US would be able to import up to 2.5 times their new capacity with no extra tariffs during an approved construction period Taiwan aims to build a “democratic” high-tech supply chain with the US and form a strategic artificial intelligence (AI) partnership under the new tariffs deal it sealed with Washington last week, Taipei’s top negotiator in the talks said yesterday. US President Donald Trump has pushed Taiwan, a major producer of semiconductors which runs a large trade surplus with the US, to invest more in the US, specifically in chips that power AI. Under the terms of the long-negotiated deal, chipmakers such as Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) that expand US production would incur a lower tariff on semiconductors or related manufacturing
RSS